Clean Yield Group who had been investing in Telus Corp Com for a number of months, seems to be less bullish one the $22.06 billion market cap company. The stock increased 0.34% or $0.11 during the last trading session, reaching $32.2. About 421,917 shares traded or 10.53% up from the average. Bank of America Corporation (NYSE:BAC) has risen 58.64% since January 28, 2017 and is uptrending. It has outperformed by 24.82% the S&P500.
Skytop Capital Management Llc decreased Cyrusone Inc (CONE) stake by 27.27% reported in 2017Q3 SEC filing. Winfield Associates Inc bought 13,050 shares as the company's stock rose 15.46% with the market. The institutional investor held 103,980 shares of the real estate investment trusts company at the end of 2017Q3, valued at $6.13M, down from 115,580 at the end of the previous reported quarter. Winfield Associates Inc who had been investing in Cyrusone Inc Com for a number of months, seems to be bullish on the $5.09B market cap company. LP now owns 1,227,328 shares of the real estate investment trust's stock valued at $72,326,000 after acquiring an additional 67,265 shares during the last quarter. Another trade for 2,522 shares valued at $616,499 was made by Verbeck Robert E on Monday, July 31. Mondelez International, Inc. (NASDAQ:MDLZ) has risen 5.69% since January 26, 2017 and is uptrending. It has underperformed by 7.13% the S&P500. During the same quarter last year, the firm posted $0.67 earnings per share. analysts anticipate that CyrusOne Inc will post 3.08 EPS for the current fiscal year. Therefore 64% are positive. Cyrusone Inc had 57 analyst reports since August 6, 2015 according to SRatingsIntel. The rating was maintained by Jefferies on Friday, September 1 with "Buy". RBC Capital Markets maintained CyrusOne Inc. On Tuesday, September 5 the stock rating was maintained by RBC Capital Markets with "Buy". Cyrusone Inc now has $5.09 billion valuation. The rating was initiated by Guggenheim on Friday, December 2 with "Buy". The firm has "Buy" rating by Cowen & Co given on Thursday, September 21. The firm has "Buy" rating given on Tuesday, November 24 by Suntrust Robinson. Jefferies maintained it with "Buy" rating and $6300 target in Monday, July 24 report. The firm has "Buy" rating given on Monday, July 17 by Stifel Nicolaus. The firm has "Overweight" rating by JP Morgan given on Friday, November 20. The stock of Diageo plc (NYSE:DEO) earned "Hold" rating by Deutsche Bank on Thursday, March 17.
Alliancebernstein L.P. increased its holdings in shares of CyrusOne by 1.5% during the 2nd quarter. The company has a current ratio of 0.48, a quick ratio of 0.48 and a debt-to-equity ratio of 1.56. It fall, as 50 investors sold BA shares while 609 reduced holdings. Vaughan Nelson Investment Management L.P. raised its position in CyrusOne by 37.1% during the 4th quarter. PNC Financial Services Group Inc. now owns 3,031 shares of the real estate investment trust's stock worth $169,000 after buying an additional 751 shares during the period. Beese Fulmer Inv Management Incorporated reported 22,337 shares. Ancora Ltd Liability holds 89,022 shares or 0.3% of its portfolio. Tci Wealth Advsrs Inc holds 0% of its portfolio in Nektar Therapeutics (NASDAQ:NKTR) for 192 shares. Santa Barbara Asset Mngmt Ltd Limited Liability Company invested 1.04% of its portfolio in CyrusOne Inc.
Shares of CyrusOne (NASDAQ CONE) opened at $58.82 on Friday. Jennison Associates LLC owned approximately 1.70% of CyrusOne worth $92,197,000 as of its most recent filing with the Securities and Exchange Commission. D L Carlson Investment Gru stated it has 40,165 shares. Swiss Bank & Trust has 0.01% invested in CyrusOne Inc. Cornerstone Mngmt Limited Liability has invested 0.02% in CyrusOne Inc. (NASDAQ:CONE). 329,105 were accumulated by Eagle Asset Mngmt Inc. Pub Employees Retirement System Of Ohio invested 0.01% in CyrusOne Inc. Tealwood Asset Management holds 90,590 shares. UBS Group reissued a "buy" rating and issued a $70.00 target price (up previously from $63.00) on shares of CyrusOne in a report on Wednesday, November 1st. (NASDAQ:CONE). Century Companies Inc holds 0.03% in CyrusOne Inc. (NASDAQ:CONE) or 725,101 shares. Two equities research analysts have rated the stock with a sell rating, two have assigned a hold rating and twelve have issued a buy rating to the company. Therefore 65% are positive. Nektar Therapeutics had 21 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has "Buy" rating given on Friday, July 7 by Jefferies. The rating was maintained by KeyBanc Capital Markets on Thursday, October 12 with "Hold". UBS has "Neutral" rating and $27 target. On Wednesday, November 8 the stock rating was maintained by Jefferies with "Buy". Vetr downgraded Bank of America Corporation (NYSE:BAC) rating on Tuesday, August 11. CyrusOne now has an average rating of "Buy" and an average target price of $66.92. The rating was downgraded by Gabelli to "Hold" on Thursday, August 20. The firm earned "Buy" rating on Monday, July 18 by Deutsche Bank. The stock has "Buy" rating by Roth Capital on Tuesday, May 30. Credit Agricole upgraded the shares of BAC in report on Friday, January 29 to "Outperform" rating.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.